Circulating endothelial progenitor cells as a marker of left ventricular pump function in ischemic chronic heart failure
The goal of the study was to explore whether the quantity of endothelial progenitor cells (EPCs) associates with ischemic chronic heart failure (CHF) phenotypes. Materials and methods. Inclusion criteria met 82 patients with ischemic CHF. Sick persons with global left ventricular ejection fractio...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2017-12-01
|
| Series: | Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki |
| Subjects: | |
| Online Access: | http://pharmed.zsmu.edu.ua/article/view/113561/110370 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850056877591756800 |
|---|---|
| author | A. A. Kremzer |
| author_facet | A. A. Kremzer |
| author_sort | A. A. Kremzer |
| collection | DOAJ |
| description | The goal of the study was to explore whether the quantity of endothelial progenitor cells (EPCs) associates with ischemic chronic heart failure (CHF) phenotypes.
Materials and methods. Inclusion criteria met 82 patients with ischemic CHF. Sick persons with global left ventricular ejection fraction >40 % were graded as the HFpEF group (n = 39) and others with ≤40 % as the HFrEF group (n = 43). The levels of biomarkers in serum were measured at starting point. The method of flow cytometry was used for predictably distinguishing circulating cell subsets depending on expression of CD45, CD34, CD14, Tie-2, and CD309 antigens.
Results. In multivariate logistic regression model galectin-3 (R2 = 0.67;P = 0.012), T2DM (R2 = 0.26;P=0.001), previous MI (R2 = 0.17;P = 0.012), obesity (R2 = 0.22;P = 0.001), CD14+CD309+ cells (R2 = 0.058;P = 0.001), and CD14+СD309+Tie-2+ cells (R2 = 0.044;P = 0.028), NT-proBNP (R2 = 0.11;P = 0.046) were found as autonomous predictors of HFpEF. With help of multivariate Cox-regression analysis we found out, that NT-proBNP (OR 1.08; 95 % CI = 1.03–1.12; P = 0.001) and number of CD14+CD309+ cells (OR 1.07; 95 % CI = 1.02–1.11; P = 0.05) were independent predictors for HFpEF. The quantity of CD14+CD309+ cells added to NT-proBNP had more exact predictive value (OR 1.10; 95 % CI = 1.04–1.14; P = 0.001) than these biomarkers unaccompanied.
Conclusion: quantity of NT-proBNP added to CD14+CD309+ cells, cardiovascular risk influences and clinical information exhibited the best discriminate importance to differentiate HFpEF from HFrEF. |
| format | Article |
| id | doaj-art-bf434b3b9fba4a8abb7b4c32d85545f0 |
| institution | DOAJ |
| issn | 2306-8094 2409-2932 |
| language | English |
| publishDate | 2017-12-01 |
| publisher | Zaporizhzhia State Medical and Pharmaceutical University |
| record_format | Article |
| series | Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki |
| spelling | doaj-art-bf434b3b9fba4a8abb7b4c32d85545f02025-08-20T02:51:35ZengZaporizhzhia State Medical and Pharmaceutical UniversityAktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki2306-80942409-29322017-12-01330230510.14739/2409-2932.2017.3.113561Circulating endothelial progenitor cells as a marker of left ventricular pump function in ischemic chronic heart failureA. A. KremzerThe goal of the study was to explore whether the quantity of endothelial progenitor cells (EPCs) associates with ischemic chronic heart failure (CHF) phenotypes. Materials and methods. Inclusion criteria met 82 patients with ischemic CHF. Sick persons with global left ventricular ejection fraction >40 % were graded as the HFpEF group (n = 39) and others with ≤40 % as the HFrEF group (n = 43). The levels of biomarkers in serum were measured at starting point. The method of flow cytometry was used for predictably distinguishing circulating cell subsets depending on expression of CD45, CD34, CD14, Tie-2, and CD309 antigens. Results. In multivariate logistic regression model galectin-3 (R2 = 0.67;P = 0.012), T2DM (R2 = 0.26;P=0.001), previous MI (R2 = 0.17;P = 0.012), obesity (R2 = 0.22;P = 0.001), CD14+CD309+ cells (R2 = 0.058;P = 0.001), and CD14+СD309+Tie-2+ cells (R2 = 0.044;P = 0.028), NT-proBNP (R2 = 0.11;P = 0.046) were found as autonomous predictors of HFpEF. With help of multivariate Cox-regression analysis we found out, that NT-proBNP (OR 1.08; 95 % CI = 1.03–1.12; P = 0.001) and number of CD14+CD309+ cells (OR 1.07; 95 % CI = 1.02–1.11; P = 0.05) were independent predictors for HFpEF. The quantity of CD14+CD309+ cells added to NT-proBNP had more exact predictive value (OR 1.10; 95 % CI = 1.04–1.14; P = 0.001) than these biomarkers unaccompanied. Conclusion: quantity of NT-proBNP added to CD14+CD309+ cells, cardiovascular risk influences and clinical information exhibited the best discriminate importance to differentiate HFpEF from HFrEF.http://pharmed.zsmu.edu.ua/article/view/113561/110370heart failurepreserved left ventricular functionbiomarkersendothelial progenitor cells |
| spellingShingle | A. A. Kremzer Circulating endothelial progenitor cells as a marker of left ventricular pump function in ischemic chronic heart failure Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki heart failure preserved left ventricular function biomarkers endothelial progenitor cells |
| title | Circulating endothelial progenitor cells as a marker of left ventricular pump function in ischemic chronic heart failure |
| title_full | Circulating endothelial progenitor cells as a marker of left ventricular pump function in ischemic chronic heart failure |
| title_fullStr | Circulating endothelial progenitor cells as a marker of left ventricular pump function in ischemic chronic heart failure |
| title_full_unstemmed | Circulating endothelial progenitor cells as a marker of left ventricular pump function in ischemic chronic heart failure |
| title_short | Circulating endothelial progenitor cells as a marker of left ventricular pump function in ischemic chronic heart failure |
| title_sort | circulating endothelial progenitor cells as a marker of left ventricular pump function in ischemic chronic heart failure |
| topic | heart failure preserved left ventricular function biomarkers endothelial progenitor cells |
| url | http://pharmed.zsmu.edu.ua/article/view/113561/110370 |
| work_keys_str_mv | AT aakremzer circulatingendothelialprogenitorcellsasamarkerofleftventricularpumpfunctioninischemicchronicheartfailure |